eNeura Therapeutics, which won an FDA nod for its transcranial magnetic stimulation device for migraine last year, adds another $1.6 million to its coffers.
eNeura Therapeutics added to the $2.2 million it raised earlier this year with another $1.6 million deposit, part of a hoped-for $2 million funding round, according to a regulatory filing.
Sunnyvale, Calif.-based eNeura makes a transcranial magnetic stimulation device designed to treat migraine headaches.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1i6P9QO
Cap comentari:
Publica un comentari a l'entrada